Tag: Tillotts
Tillotts Pharma AG announces that DIFICLIRTM (Fidaxomicin) is recommended by ESCMID for the treatment of Clostridioides difficile infections (CDI)
RHEINFELDEN, Switzerland – Tillotts Pharma AG (“Tillotts”), part of the Japanese Zeria Group, welcomes the recommendation that DIFICLIRTM (Fidaxomicin) as an initial treatment and treatment of the first relapse of…